The DOI matches its Crossref record; 228 of the 228 references it cites were found in a registry or an index.
Mitochondrial energetics in the kidney
Open accessAbstract
The kidney requires a large number of mitochondria to remove waste from the blood and regulate fluid and electrolyte balance. Mitochondria provide the energy to drive these important functions and can adapt to different metabolic conditions through a number of signalling pathways (for example, mechanistic target of rapamycin (mTOR) and AMP-activated protein kinase (AMPK) pathways) that activate the transcriptional co-activator peroxisome proliferator-activated receptor-γ co-activator 1α (PGC1α), and by balancing mitochondrial dynamics and energetics to maintain mitochondrial homeostasis. Mitochondrial dysfunction leads to a decrease in ATP production, alterations in cellular functions and structure, and the loss of renal function. Persistent mitochondrial dysfunction has a role in the early stages and progression of renal diseases, such as acute kidney injury (AKI) and diabetic nephropathy, as it disrupts mitochondrial homeostasis and thus normal kidney function. Improving mitochondrial homeostasis and function has the potential to restore renal function, and administering compounds that stimulate mitochondrial biogenesis can restore mitochondrial and renal function in mouse models of AKI and diabetes mellitus. Furthermore, inhibiting the fission protein dynamin 1-like protein (DRP1) might ameliorate ischaemic renal injury by blocking mitochondrial fission.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–228 of 228
Mortality and Renal Disease in Type 1 Diabetes Mellitus—Progress Made, More to Be Done
Maahs, D. M., & Rewers, M. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-1730 · Cited by 71
Misconceptions about Aerobic and Anaerobic Energy Expenditure
Scott, C. B. (2005) · Journal of the International Society of Sports Nutrition · doi:10.1186/1550-2783-2-2-32 · Cited by 70
Mitochondrial Sirtuin 3 and Renal Diseases
Perico, L., Morigi, M., & Benigni, A. (2016) · The Nephron journals/Nephron journals · doi:10.1159/000444370 · Cited by 70
Halseth, A. E., Ensor, N. J., White, T., Ross, S. A., & Gulve, E. A. (2002) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)00557-0 · Cited by 69
Nix: A receptor protein for mitophagy in mammals
Kanki, T. (2010) · Autophagy · doi:10.4161/auto.6.3.11420 · Cited by 69
Inner medullary lactate production and accumulation: a vasa recta model
Thomas, S. (2000) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.2000.279.3.f468 · Cited by 62
mTORC2 critically regulates renal potassium handling
Grahammer, F., Nesterov, V., Ahmed, A., Steinhardt, F., Sandner, L., Arnold, F., Cordts, T., Negrea, S., Bertog, M., Rüegg, M. A., et al. (2016) · Journal of Clinical Investigation · doi:10.1172/jci80304 · Cited by 62
Rheb and mammalian target of rapamycin in mitochondrial homoeostasis
Groenewoud, M. J., & Zwartkruis, F. J. T. (2013) · Open Biology · doi:10.1098/rsob.130185 · Cited by 57
Idrovo, J. P., Yang, W.-L., Nicastro, J. M., Coppa, G. F., & Wang, P. (2012) · Journal of Surgical Research · doi:10.1016/j.jss.2012.05.053 · Cited by 54
UCP2 attenuates apoptosis of tubular epithelial cells in renal ischemia-reperfusion injury
Zhou, Y., Cai, T., Xu, J., Jiang, L., Wu, J., Sun, Q., Zen, K., & Yang, J. (2017) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00118.2017 · Cited by 53
Mitophagy: Basic Mechanism and Potential Role in Kidney Diseases
Tang, C., He, L., Liu, J., & Dong, Z. (2015) · Kidney Diseases · doi:10.1159/000381510 · Cited by 51
Bnip3-mediated defects in oxidative phosphorylation promote mitophagy
Thomas, R. L., Kubli, D. A., & Gustafsson, Å. B. (2011) · Autophagy · doi:10.4161/auto.7.7.15536 · Cited by 48
Chung, B. H., Lim, S. W., Ahn, K. O., Sugawara, A., Ito, S., Choi, B. S., Kim, Y., Bang, B. K., & Yang, C. W. (2005) · Nephrology · doi:10.1111/j.1440-1797.2005.00456.x · Cited by 46
IHG-1 Promotes Mitochondrial Biogenesis by Stabilizing PGC-1α
Hickey, F. B., Corcoran, J. B., Docherty, N. G., Griffin, B., Bhreathnach, Ú., Furlong, F. M., Martin, F., Godson, C., & Murphy, M. (2011) · Journal of the American Society of Nephrology · doi:10.1681/asn.2010111154 · Cited by 41
Portilla, D. (1999) · Current Opinion in Nephrology & Hypertension · doi:10.1097/00041552-199907000-00012 · Cited by 40
Early protective effect of mitofusion 2 overexpression in STZ-induced diabetic rat kidney
Tang, W. X., Wu, W. H., Zeng, X., Bo, H., & Huang, S. (2011) · Endocrine · doi:10.1007/s12020-011-9555-1 · Cited by 37
Modeling glucose metabolism and lactate production in the kidney
Chen, Y., Fry, B. C., & Layton, A. T. (2017) · Mathematical Biosciences · doi:10.1016/j.mbs.2017.04.008 · Cited by 36
Therapeutic targeting of the mitochondrial dysfunction in septic acute kidney injury
Parikh, S. M. (2013) · Current Opinion in Critical Care · doi:10.1097/mcc.0000000000000038 · Cited by 34
Singh, J., Singh, A. P., & Bhatti, R. (2013) · Journal of Surgical Research · doi:10.1016/j.jss.2013.11.1088 · Cited by 34
Eklund, T., Wahlberg, J. A., Ungerstedt, U., & Hillered, L. (1991) · Acta Physiologica Scandinavica · doi:10.1111/j.1748-1716.1991.tb09233.x · Cited by 32
de Souza, B. M., Michels, M., Sortica, D. A., Bouças, A. P., Rheinheimer, J., Buffon, M. P., Bauer, A. C., Canani, L. H. S., & Crispim, D. (2015) · PLoS ONE · doi:10.1371/journal.pone.0132938 · Cited by 30
Svensson, K., Schnyder, S., Cardel, B., & Handschin, C. (2016) · PLoS ONE · doi:10.1371/journal.pone.0158716 · Cited by 28
Selewski, D. T., & Symons, J. M. (2014) · Pediatrics in Review · doi:10.1542/pir.35-1-30 · Cited by 26
Al-Rasheed, N. M., Al‐Rasheed, N. M., Alamin, M. A., Hasan, I. H., Al‐Ajmi, H. N., Ahmed, M., & Attia, H. (2016) · Archives of Physiology and Biochemistry · doi:10.3109/13813455.2016.1164186 · Cited by 26
IHG-1 Increases Mitochondrial Fusion and Bioenergetic Function
Hickey, F. B., Corcoran, J. B., Griffin, B., Bhreathnach, Ú., Mortiboys, H., Reid, H. M., Andrews, D. C., Byrne, S., Furlong, F. M., Martin, F., et al. (2014) · Diabetes · doi:10.2337/db13-1256 · Cited by 25
Paraskevas, K. I., & Mikhailidis, D. P. (2016) · Angiology · doi:10.1177/0003319716668934 · Cited by 25
Tapping into Mitochondria to Find Novel Targets for Diabetes Complications
Flemming, N., Gallo, L. A., Ward, M. S., & Forbes, J. M. (2016) · Current Drug Targets · doi:10.2174/1389450116666150727114410 · Cited by 24
Cardiovascular Events after AKI: A New Dimension
Hsu, C., & Liu, K. D. (2014) · Journal of the American Society of Nephrology · doi:10.1681/asn.2013121276 · Cited by 15
Cited by
Peerapornratana, S., Manrique-Caballero, C. L., Gómez, H., & Kellum, J. A. (2019) · Kidney International · doi:10.1016/j.kint.2019.05.026 · Cited by 1,471
The sirtuin family in health and disease
Wu, Q.-J., Zhang, T.-N., Chen, H.-H., Yu, X.-F., Lv, J.-L., Liu, Y.-Y., Liu, Y.-S., Zheng, G., Zhao, J.-Q., Wei, Y.-F., et al. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01257-8 · Cited by 862
Zhao, M., Wang, Y., Li, L., Liu, S., Wang, C., Yuan, Y., Yang, G., Chen, Y., Cheng, J., Lu, Y., et al. (2021) · Theranostics · doi:10.7150/thno.50905 · Cited by 820
Mitochondrial quality control in kidney injury and repair
Tang, C., Cai, J., Yin, X.-M., Weinberg, J. M., Venkatachalam, M. A., & Dong, Z. (2021) · Nature Reviews Nephrology · doi:10.1038/s41581-020-00369-0 · Cited by 513
Signaling pathways of chronic kidney diseases, implications for therapeutics
Yuan, Q., Tang, B., & Zhang, C. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01036-5 · Cited by 453
Metadata
- Authors
- Bhargava, P., & Schnellmann, R. G.
- Venue
- Nature Reviews Nephrology
- Published
- 2017-08-14
- Volume
- 13
- Issue
- 10
- Pages
- 629-646
- ISSN
- 1745-8323 (ISSN-L)
- 1759-5061
- 1759-507X
- OpenAlex
- W2750514629
- Cited by
- 1,334
- References
- 228
- FWCI
- 4.42
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.